                         SEQUENCE LISTING

<110>  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE 
       SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
 
<120>  HER2-SPECIFIC MONOCLONAL ANTIBODIES AND CONJUGATES THEREOF

<130>  4239-91229-02

<150>  US 61/833,732
<151>  2013-06-11

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide

<400>  1
gaagtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc agctactgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga taccagatac      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccatcag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagacagtat      300

agtggctacg acagatacta ctttgactac tggggccagg gaaccctggt caccgtctct      360

tca                                                                    363


<210>  2
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  2

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Ser Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Cys Asp Arg Ser Asp Thr Arg Tyr Ser 
    50                  55                  60                  


Pro Ser Phe Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser 
65                  70                  75                  80  


Thr Ala Tyr Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met 
                85                  90                  95      


Tyr Tyr Cys Ala Arg Gln Tyr Ser Gly Tyr Asp Arg Tyr Tyr Phe Asp 
            100                 105                 110         


Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  3
<211>  333
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide

<400>  3
cagactgtgg tgacccagga gccatcgttc tcagtgtccc ctggagggac agtcacactc       60

acttgtggct tgaactctgg ctcagtctca actcgtcact accccagctg gtaccagcag      120

accccaggcc aggctccacg cacgctcatc tacagcacag atattcgctc ttctggggcc      180

cctagtcaca tctctggctc catccttggg aacaaagctg ccctcaccat cacgggggcc      240

caggcagatg atgcatctga ttattactgt gcgctctatt tgggtaatgg cattgctgtc      300

ttcggatctg ggaccaaggt caccgtccta ggt                                   333


<210>  4
<211>  114
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  4

Gln Thr Val Val Thr Gln Glu Pro Ser Phe Ser Val Ser Pro Gly Gly 
1               5                   10                  15      


Thr Val Thr Leu Thr Cys Gly Leu Asn Ser Gly Ser Val Ser Thr Arg 
            20                  25                  30          


His Tyr Pro Ser Trp Tyr Gln Gln Thr Pro Gly Gln Ala Pro Arg Thr 
        35                  40                  45              


Leu Ile Tyr Ser Thr Asp Ile Cys Asp Arg Arg Ser Ser Gly Ala Pro 
    50                  55                  60                  


Ser His Ile Ser Gly Ser Ile Leu Gly Asn Lys Ala Ala Leu Thr Ile 
65                  70                  75                  80  


Thr Gly Ala Gln Ala Asp Asp Ala Ser Asp Tyr Tyr Cys Ala Leu Tyr 
                85                  90                  95      


Leu Gly Asn Gly Ile Ala Val Phe Gly Ser Gly Thr Lys Val Thr Val 
            100                 105                 110         


Leu Gly 
        


